- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Immunex/Berlex
Total 3501 results
-
St. Jude Children's Research HospitalNational Institutes of Health (NIH); Immunex/BerlexCompletedOsteosarcomaUnited States, Chile
-
AmgenImmunex CorporationTerminatedJuvenile Rheumatoid Arthritis
-
AmgenImmunex CorporationCompleted
-
AmgenImmunex CorporationCompletedJuvenile Rheumatoid Arthritis
-
AmgenImmunex CorporationCompletedRheumatoid Arthritis
-
AmgenImmunex CorporationCompletedPsoriasis | Psoriatic Arthritis
-
AmgenImmunex CorporationCompleted
-
AbgenixImmunex CorporationCompletedProstate CancerUnited States
-
AmgenImmunex CorporationCompleted
-
AmgenImmunex CorporationCompleted
-
Immune DesignTerminatedMelanoma | Sarcoma | Ovarian Cancer | Non-small Cell Lung CancerUnited States
-
Immune PharmaceuticalsUnknownUlcerative Colitis, Active Severe | Ulcerative Colitis, Active ModerateIsrael
-
Immune ControlUnknownMultiple MyelomaUnited States
-
Immune DesignTerminatedSarcoma | Soft Tissue Sarcoma | Cancer | Synovial Sarcoma | Metastatic SarcomaUnited States, Canada
-
Immune DesignCompletedMerkel Cell CarcinomaUnited States
-
Immune PharmaceuticalsCompletedPemphigoid, BullousUnited States, Israel
-
Immune DesignCompletedMelanoma | Sarcoma | Breast Cancer | Ovarian Cancer | Non-small Cell Lung CancerUnited States
-
Massachusetts General HospitalImmunex CorporationTerminatedPsoriasisUnited States
-
Smart Immune SASRecruitingHealthy VolunteersFrance
-
Immune Biosolutions IncCompletedCOVID-19South Africa, Ukraine
-
Repertoire Immune MedicinesTerminatedRPTR-168 in Patients With Human Papillomavirus Strain 16 (HPV-16) E6/E7 Positive Tumors and MelanomaMelanoma | Cervical Cancer | Head and Neck Squamous Cell CarcinomaUnited States
-
Repertoire Immune MedicinesTerminatedMelanoma | Head and Neck Cancer | HPV-Related Malignancy | Melanoma (Skin) | HPV-Related Carcinoma | HPV-Related Cervical Carcinoma | HPV Positive Oropharyngeal Squamous Cell Carcinoma | Lung Cancer, Nonsmall CellUnited States
-
Intervene Immune, Inc.RecruitingImmunosenescence | Epigenetic AgingUnited States
-
Immune-Onc TherapeuticsActive, not recruitingSolid Tumor, AdultUnited States
-
Immune Biosolutions IncCompleted
-
Smart Immune SASRecruiting
-
Immune-Onc TherapeuticsRecruitingAdvanced Solid TumorChina
-
Smart Immune SASRecruitingHematological MalignanciesUnited States
-
Immune Biosolutions IncCompletedCOVID-19Ukraine, South Africa
-
University of Wisconsin, MadisonImmunex CorporationCompletedHIV InfectionsUnited States
-
Immunic AGActive, not recruitingRelapsing-Remitting Multiple Sclerosis (RRMS)Poland, Bulgaria, Romania, Ukraine
-
NImmune BiopharmaTerminatedCrohn's DiseaseUnited States
-
NImmune BiopharmaCompletedNormal Healthy VolunteersAustralia
-
NImmune BiopharmaWithdrawn
-
Immune Oncology Research InstituteRecruitingContinuous Infusion of First-Generation 5-HT3 Receptor Antagonists in Combination With DexamethasonePediatric CancerArmenia
-
Natural Immune Systems IncRecruitingImmune SurveillanceUnited States
-
Immune System Regulation ABUnknownHIV-1-infectionSweden, Germany
-
Immune System Key LtdWithdrawnMyelodysplastic Syndromes | Acute Myelogenous LeukemiaIsrael
-
Immune DesignGenentech, Inc.TerminatedSarcoma | Myxoid/Round Cell Liposarcoma | Liposarcoma | Synovial Sarcoma | Recurrent Adult Soft Tissue Sarcoma | Metastatic Sarcoma | Locally Advanced SarcomaUnited States
-
Natural Immune Systems IncCompleted
-
Natural Immune Systems IncCompletedRange of MotionUnited States
-
Natural Immune Systems IncCompleted
-
Immune Targeting Systems LtdCompleted
-
Immutep S.A.S.RecruitingBreast CarcinomaSpain, United States, Belgium
-
Immunis, Inc.RecruitingMuscle AtrophyUnited States